Regulation of NT Receptors after Chronic Treatment with Typical and Atypical Neuroleptic Drugs
Neurotensin is a tridecapeptide, which produces central effects such as hypotension, hypothermia, muscle relaxation, analgesia, antinociception, and reduces locomotor activity (Nemeroff et al., 1977). In the recent years, several lines of evidences indicated the great importance of the dopamine (DA)- neurotensin (NT) interaction taking place mostly in the mesolimbocortical areas, both at cell bodies (A10 DA-ergic group located in the ventral tegmental area -VTA-) and nerve terminal level (cerebral cortex, n. accumbens, olfactory tubercle, ventral n. caudato-putamen) (Quirion, 1983; Nemeroff, et al., 1984; Nemeroff, 1986). Immunocytochemical data indicated the presence of NT-like immunoreactivity in DA cell bodies in the VTA, including midline structures, with only single example of coexistence in the substantia nigra (Hokfelt et al., 1984). Anatomical data indicate that NT-like immunoreactive fibres, nerve terminals and also cell bodies are present in the basal ganglia (Kalivas, 1984; Sugimoto and Mizuno, 1987; Uhl et al, 1979). NT receptors are localized on the DA-ergic cell bodies in the ventral mesencephalon (Young and Kuhar, 1981). NT receptors are also reported to exist in the basal ganglia of the rat, on DA nerve terminals, intrinsic neurons and corticostriatal fibres (FIG. 1) (Quirion et al, 1985; Goedert et al., 1984).
KeywordsVentral Tegmental Area Olfactory Tubercle Ventral Mesencephalon Neurotensin Receptor Receptor Balance
Unable to display preview. Download preview PDF.
- Biorklund, A., and Lindvall, O., 1984, Dopamine containing systems in the CNS, in: “Handbook of Chemical Neuroanatomy. Vol. 2: Classical Transmitters in the CNS, Part I,” A. Biorklund and T. Hokfelt, eds., Elsevier, Amsterdam.Google Scholar
- Fabbri, P.L., Agnati, L.F., Fuxe, K., Battistini, N., Zini, I., and Zoli, M., 1985, Principles for the construction of the software for image analysis of transmitteridentified neurons, in: “Quantitative Neuroanatomy in Transmitter Research,” L.F. Agnati and K. Fuxe, eds., Macmillan Press, London.Google Scholar
- Giardino, L., Calzà, L., Piazza, P.V., and Amato, G., 1990, Opiate receptor modifications in the rat brain after chronic treatment with haloperidol and sulpiride, J. Psychopharm., 4, in press.Google Scholar
- Covoni, S., Hong, J.S., Yang, H.-Y., and Costa, E., 1980, Increase of neurotensin content elicited by neuroleptics in nucleus accumbens, J. Pharm. Exp. Ther., 215: 413.Google Scholar
- Graybiel, A.M., and Ragsdale, C.W., Jr., 1983, Biochemical anatomy of the striatum, in: “Chemical Neuroanatomy,” P.C. Emson, ed., Raven Press, New York.Google Scholar
- McEachron, D.L., 1986, Functional mapping in biology and medicine: computer assisted autoradiography, Karger, Basel.Google Scholar
- Nemeroff, C.B., Kalivas, P.W., and Prange, A.J., Jr., 1984, Interaction of neurotensin and dopamine in limbic structures, in: “Catecholamines: Neuropharmacology and Central Nervous System - Theoretical aspects,” E. Usdin, A. Carlsson, A. Dahlstrom, eds., Alan R. Liss, New York (1984).Google Scholar
- Paxinos, G., and Watson, C., 1986, The rat brain in stereotaxic coordinates, Academic Press, New York.Google Scholar
- Piazza, P.V., Calzà, L., Giardino, L., and Amato, G., 1990, Chronic thioridazine treatment differently affects DA receptors in striatum and in mesolimbo-cortical systems, Pharm. Biochem. Behay., 35, in press.Google Scholar
- Radke, J.M., MacLennan, A.J., Beinfeld, M.C., Bissette, G., Nemeroff, C.B., Vincent, S.R., and Fibiger, H.C., 1989, Effects of short-and long-term haloperidol administration and withdrawal on regional brain cholecystokinin and neurotensin concentrations in the rat, Brain Res., 480: 176.CrossRefGoogle Scholar